Quorum Review Launches New Site Enrollment Service
Quorum Review IRB, industry member in central IRB services, unveils today a Site Enrollment Service as part of their 2013 platform of ethics review services.
Quorum’s Site Enrollment Service allows customers to delegate the IRB startup component of clinical research for minimal cost. Quorum Review Site Support personnel will reach out to the research sites identified by the sponsor/CRO to support those sites through the submission process. The sponsor/CRO will receive on-going status updates.
As Quorum Review CEO Cami Gearhart, JD, explains, this service provides a new level of site management within the study start up process. “Site start-up that is quick and efficient is mission-critical for our customers. By leveraging the expertise of our site support team, we can help our customers streamline the collection of study start-up documentation.”
While the service is focused on the initial site submission phase to the IRB, clients have access to the service any time a new site is considered for participation in a central study. More information on the new Site Enrollment Service and all of Quorum’s ethics review services can be found at www.quorumreview.com.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
